COMP <GO>
AHR vs BRK-B // ALTMAN Z-SCORE & DEBT/EQUITY
American Healthcare REIT Inc. (NYSE) VS. Berkshire Hathaway Inc. (NYSE) • 15-METRIC TALLY: AHR 5
— BRK-B 9
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: AHR
LAST: $53.52 (+1.10%) • MKT CAP: $12.34B
balance-sheet
4.12
LAST: $542.49 (+0.10%) • MKT CAP: $1.16T
balance-sheet
2.85
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AHR VS. BRK-B)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AHR | BRK-B | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 14.40% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.10% | 11.47% | -3.37 | BRK-B | /roic <GO> |
| EV/EBITDA & P/E Valuation | 26.4x | 9.7x | +16.72 | BRK-B | /valuation <GO> |
| Free Cash Flow Yield | 1.62% | 2.09% | -0.47 | BRK-B | /fcf-yield <GO> |
| Operating Margin | 19.80% | 27.80% | -8.00 | BRK-B | /operating-margins <GO> |
| Net Profit Margin | 3.40% | 22.30% | -18.90 | BRK-B | /net-margins <GO> |
| Revenue Growth (YoY) | 11.20% | 3.93% | +7.27 | AHR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.32% | 0.00% | +1.32 | AHR | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 4.12 | 2.85 | +1.27 | AHR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 4/9 | +4.00 | AHR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.30% | 3.55% | +3.75 | BRK-B | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.6 | 66.8 | -12.18 | BRK-B | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.11 | 0.61 | +0.50 | AHR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 140.0x | 24.3x | +115.66 | BRK-B | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $12.34B | $1.16T | -$1.15T | BRK-B | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AHR REV | BRK-B REV | AHR GROSS % | BRK-B GROSS % | AHR FCF | BRK-B FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.09B | $371.44B | 14.4% | — | $200.2M | $25.04B |
| FY 2024 | $1.88B | $371.43B | 12.2% | — | $91.3M | $11.62B |
| FY 2023 | $1.67B | $364.48B | 44.0% | — | $23.4M | $29.79B |
| FY 2022 | — | $302.02B | — | — | — | $21.89B |
| FY 2021 | — | $276.19B | — | — | — | $26.15B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AHR // BETA 1.11
BRK-B // BETA 0.61